The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Analyzing stochastic cell-to-cell variability can potentially reveal causal interactions in gene regulatory networks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback